APA (7th ed.) Citation

Hirano, I., Collins, M., Assouline-Dayan, Y., Evans, L., Gupta, S., Schoepfer, A., . . . Dellon, E. (2018). A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY RPC4046 IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS. Annals of allergy, asthma, & immunology, 121(5), S15. https://doi.org/10.1016/j.anai.2018.09.047

Chicago Style (17th ed.) Citation

Hirano, I., et al. "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY RPC4046 IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS." Annals of Allergy, Asthma, & Immunology 121, no. 5 (2018): S15. https://doi.org/10.1016/j.anai.2018.09.047.

MLA (9th ed.) Citation

Hirano, I., et al. "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY RPC4046 IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS." Annals of Allergy, Asthma, & Immunology, vol. 121, no. 5, 2018, p. S15, https://doi.org/10.1016/j.anai.2018.09.047.